IP Library Granted Patent US 8,703,206
Granted Patent B2
US 8,703,206 · App. 13/742,241 · Granted Apr 22, 2014

Placental tissue grafts

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,703,206
App. No.
13/742,241
Granted
Apr 22, 2014
Kind
B2
Abstract

Described herein are tissue grafts derived from the placenta. The grafts are composed of at least one layer of amnion tissue where the epithelium layer has been substantially removed in order to expose the basement layer to host cells. By removing the epithelium layer, cells from the host can more readily interact with the cell-adhesion bio-active factors located onto top and within of the basement membrane. Also described herein are methods for making and using the tissue grafts. The laminin structure of amnion tissue is nearly identical to that of native human tissue such as, for example, oral mucosa tissue. This includes high level of laminin-5, a cell adhesion bio-active factor show to bind gingival epithelia-cells, found throughout upper portions of the basement membrane.

Claims (5)

1. A method for treating a separated amnion membrane comprising a first side which is an epithelial cellular layer and a second side which is a fibroblast cellular layer, which method comprises contacting the separated amnion membrane with a hypertonic saline solution, wherein the hypertonic saline solution comprises a NaCl concentration from about 10% to about 30%, under conditions such that the fibroblast cellular layer is retained.

2. The method of claim 1 , further comprising

decontaminating the separated amnion membrane in said hypertonic saline solution under agitation.

3. The method of claim 1 , further comprising substantially removing the epithelial cellular layer from the separated amnion membrane.

4. The method of claim 1 , wherein the hypertonic saline solution has a NaCl concentration of about 18%.

Assignments (11)
RELEASE OF SECURITY INTEREST Recorded Feb 5, 2024
From: HAYFIN SERVICES LLP
To: MIMEDX GROUP, INC.; MIMEDX PROCESSING SERVICES, LLC
Reel/Frame 066493/0322 →
SECURITY INTEREST Recorded Jan 25, 2024
From: MIMEDX GROUP, INC.
To: CITIZENS BANK, N.A.
Reel/Frame 066371/0136 →
RELEASE OF SECURITY INTEREST Recorded Jul 2, 2020
From: BLUE TORCH FINANCE LLC, AS COLLATERAL AGENT
To: MIMEDX GROUP, INC.; MIMEDX PROCESSING SERVICES, LLC
Reel/Frame 054075/0687 →
PATENT SECURITY AGREEMENT Recorded Jul 2, 2020
From: MIMEDX GROUP, INC.; MIMEDX PROCESSING SERVICES, LLC
To: HAYFIN SERVICES LLP, AS COLLATERAL AGENT
Reel/Frame 053121/0833 →
SECURITY INTEREST Recorded Jun 11, 2019
From: MIMEDX GROUP, INC.
To: BLUE TORCH FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 049426/0863 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS Recorded Jan 24, 2019
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: MIMEDX GROUP, INC.
Reel/Frame 048121/0835 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Oct 15, 2015
From: MIMEDX GROUP, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 036872/0498 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 1, 2014
From: TOFE, ROBERT
To: SNOASIS MEDICAL, INC.
Reel/Frame 033863/0679 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 1, 2014
From: SNOASIS MEDICAL, INC.
To: SURGICAL BIOLOGICS, LLC
Reel/Frame 033863/0721 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 25, 2013
From: SURGICAL BIOLOGICS, LLC
To: MIMEDX GROUP, INC.
Reel/Frame 030880/0831 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 25, 2013
From: DANIEL, JOHN; TOFE, ROBERT; SPENCER, RANDALL; RUSSO, JOHN
To: SURGICAL BIOLOGICS, LLC
Reel/Frame 030880/0815 →